BeOne Medicines Ltd. (ONC) Insider Trading

Over the last 3 months, ONC insiders made 0 open-market buys and 38 sales, a net sale of -$7.5M (SEC Form 4). Over the last 6 months, 201 institutions increased and 177 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
38
Net (3m)
-$7.5M
Insider trades by month Buys Sells
Jan
Feb
Mar
Apr
May
Jun
Context3-month price -4%Institutions mixed (13F)
DateInsiderTypeSharesPrice
Jun 25, 2026OYLER JOHNdirector, officer: Chief Executive OfficerSell1,290$274.12
Jun 25, 2026Wu Xiaobinofficer: President and COOSell1,292$276.26
Jun 25, 2026OYLER JOHNdirector, officer: Chief Executive OfficerSell1,800$273.30
Jun 25, 2026Wang Laiofficer: President, Global Head of R&DSell1,068$276.74
Jun 25, 2026OYLER JOHNdirector, officer: Chief Executive OfficerSell320$275.10
Jun 18, 2026Lee Chan Henryofficer: SVP, General CounselSell590$265.98
Jun 18, 2026Wang Laiofficer: President, Global Head of R&DSell1,169$265.39
Jun 18, 2026Wu Xiaobinofficer: President and COOSell1,357$266.76
Jun 18, 2026OYLER JOHNdirector, officer: Chief Executive OfficerSell1,650$264.87
Jun 18, 2026OYLER JOHNdirector, officer: Chief Executive OfficerSell1,710$265.99
Jun 18, 2026OYLER JOHNdirector, officer: Chief Executive OfficerSell333$266.69
Jun 15, 2026Wu Xiaobinofficer: President and COOSell626$261.20
Jun 15, 2026Wu Xiaobinofficer: President and COOGrant229,775$20.81
Jun 15, 2026Lee Chan Henryofficer: SVP, General CounselGrant45,071—
Jun 15, 2026Lee Chan Henryofficer: SVP, General CounselSell428$257.63
Jun 15, 2026Lee Chan Henryofficer: SVP, General CounselGrant87,308$20.81
Jun 15, 2026OYLER JOHNdirector, officer: Chief Executive OfficerGrant177,931—
Jun 15, 2026OYLER JOHNdirector, officer: Chief Executive OfficerSell741$256.23
Jun 15, 2026OYLER JOHNdirector, officer: Chief Executive OfficerSell859$257.59
Jun 15, 2026OYLER JOHNdirector, officer: Chief Executive OfficerSell200$258.28
Jun 15, 2026OYLER JOHNdirector, officer: Chief Executive OfficerSell149$258.81
Jun 15, 2026OYLER JOHNdirector, officer: Chief Executive OfficerGrant344,669$20.81
Jun 15, 2026Wang Xiaodongdirector, other: Chair, Scientific Advisory BrdGrant99,892—
Jun 15, 2026Wang Xiaodongdirector, other: Chair, Scientific Advisory BrdGrant193,492$20.81
Jun 15, 2026BRANDICOURT OLIVIERdirectorGrant18,980—
Jun 15, 2026HOOPER ANTHONY CdirectorGrant18,980—
Jun 15, 2026Dugan MargaretdirectorGrant18,980—
Jun 15, 2026Sawyers Charles LazelledirectorGrant18,980—
Jun 15, 2026Sharp ShalinidirectorGrant18,980—
Jun 15, 2026Riva AlessandrodirectorGrant18,980—

Source: ONC SEC Form 4 filings, latest Jun 25, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their ONC positions over the last 6 months (SEC Form 13F).

Increased
201
New positions
164
Reduced
177
Sold out
136
Largest moves
InstitutionActionSharesFiled
BAKER BROS. ADVISORS LPUnchanged8.8MMay 15, 2026
BAKER BROS. ADVISORS LPUnchanged8.8MFeb 17, 2026
CAPITAL INTERNATIONAL INVESTORSIncreased5.1MFeb 11, 2026
PRIMECAP MANAGEMENT CO/CA/Reduced5.0MFeb 11, 2026
PRIMECAP MANAGEMENT CO/CA/Reduced5.0MMay 11, 2026
CAPITAL INTERNATIONAL INVESTORSReduced4.2MMay 13, 2026
FMR LLCIncreased4.0MFeb 17, 2026
FMR LLCReduced3.7MMay 15, 2026
OAK HILL ADVISORS LPNew Position2.8MFeb 17, 2026
THOMAS J. HERZFELD ADVISORS, INC.New Position2.1MFeb 13, 2026
SIT INVESTMENT ASSOCIATES INCNew Position1.6MFeb 25, 2026
CAPITAL WORLD INVESTORSNew Position1.6MMay 13, 2026
COMMONWEALTH EQUITY SERVICES, LLCNew Position1.5MFeb 12, 2026
PRICE T ROWE ASSOCIATES INC /MD/Reduced1.4MFeb 17, 2026
GCM GROSVENOR HOLDINGS, LLCNew Position1.4MFeb 17, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to ONC overview (price, financials, earnings)